DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: CIALIS

Summary for Tradename: CIALIS

Patents:5
Applicants:1
NDAs:1
Suppliers: see list8
2013 Sales:$1,086,355,000
drug
patent expirations by year for
 CIALIS

Pharmacology for Tradename: CIALIS

Clinical Trials for: CIALIS

Brain SPECT Following Cialis (Tadalafil ) Administration
Status: Not yet recruiting Condition: Change in Brain Perfusion

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying
Status: Completed Condition: Gastroparesis

Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension
Status: Completed Condition: Benign Prostatic Hyperplasia

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Status: Recruiting Condition: Pulmonary Arterial Hypertension; Systemic Sclerosis; Scleroderma Spectrum of Diseases; Connective Tissue Disease; Pulmonary Hypertension

A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.
Status: Completed Condition: Erectile Dysfunction

Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males
Status: Enrolling by invitation Condition: Hypotension; Spinal Cord Injury

A Study of Tadalafil in Benign Prostatic Hyperplasia
Status: Completed Condition: Benign Prostatic Hyperplasia

Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
Status: Terminated Condition: Multiple Myeloma

A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction
Status: Completed Condition: Erectile Dysfunction

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension
Status: Completed Condition: Pulmonary Hypertension

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
CIALIS
tadalafil
TABLET;ORAL021368Jan 7, 2008RXNo<disabled><disabled>
Lilly
CIALIS
tadalafil
TABLET;ORAL021368Jan 7, 2008RXNo5,859,006<disabled>YY<disabled>
Lilly
CIALIS
tadalafil
TABLET;ORAL021368Jan 7, 2008RXNo6,140,329<disabled>Y<disabled>
Lilly
CIALIS
tadalafil
TABLET;ORAL021368Jan 7, 2008RXNo6,821,975<disabled>YY<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: CIALIS

Drugname Dosage Strength RLD Submissiondate
tadalafilTablets2.5 mgCialis10/14/2008
tadalafilTablets5 mg, 10 mg and 20 mgCialis11/21/2007

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc